ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

CUSIP: N71542109

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 7 signals
Share change
-9,625,041
Put/Call ratio
0%
SEC-reported price per share
$0.78
Number of holders
47
Value change
-$8,963,813
Number of buys
22
Open additional details 1 more signal available
Number of sells
32
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
141,139,908

Security key

N71542109

Report period

Q2 2022

Institutions

47

Top holders

10

Ownership snapshot

Top reported holders of PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F Highest disclosed value: $6,354,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RTW INVESTMENTS, LP has the largest disclosed position value at $6.35M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RTW INVESTMENTS, LP's linked filing trail.
Disclosed position value Top 5
RTW INVESTMENTS, LP $6.35M
Privium Fund Management B.V. $4.75M
ADAGE CAPITAL PARTNERS GP, L.L.C. $2.99M
WELLINGTON MANAGEMENT GROUP LLP $2.79M
Opaleye Management Inc. $2.2M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$6,354,000
7,019,610 shares
— 31 Mar 2022
Privium Fund Management B.V.
13F
Company
13F
—
denominator unverified
$4,747,000
5,244,446 shares
— 31 Mar 2022
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
—
denominator unverified
$2,987,000
3,300,000 shares
— 31 Mar 2022
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$2,791,000
3,084,150 shares
— 31 Mar 2022
Opaleye Management Inc.
13F
Company
13F
—
denominator unverified
$2,195,000
2,425,000 shares
— 31 Mar 2022
FIL Ltd
13F
Company
13F
—
denominator unverified
$1,000,000
1,105,093 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
47
Shares
22,126,805
Rows available
47
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
56
Q2 2022 holders
47
Holder diff
-9
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .